![Cui Ling Wu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Cui Ling Wu
Voorzitter bij
Guangzhou Fulengen Co., Ltd.
Profiel
Momenteel is Cui Ling Wu voorzitter van de Raad van Toezicht van Guangzhou Wondfo Biotech Co., Ltd. en voorzitter van Guangzhou Fulengen Co., Ltd. Zij is tevens lid van het bestuur van Da An Gene Co., Ltd. van de Sun Yat-sen University en adjunct-directeur van het Guangzhou Bio-tech Pharmaceuticals Center en hoogleraar aan de Sun Yat-Sen University. Zij behaalde haar doctoraal aan de Farmaceutische Universiteit van Guangdong.
Actieve functies van Cui Ling Wu
| Bedrijven | Functie | Begin |
|---|---|---|
Sun Yat-Sen University
 Sun Yat-Sen University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 09-03-2010 |
Guangzhou Bio-tech Pharmaceuticals Center | Corporate Officer/Principal | 01-03-2001 |
Guangzhou Fulengen Co., Ltd.
 Guangzhou Fulengen Co., Ltd. Guangzhou Fulengen Co., Ltd. is a biotechnology and life science research company specializing in genome editing tools, gene function research, and molecular biology products. The company is based in Guangzhou, China. The Chinese company develops and promotes a broad portfolio of products, including full-length cDNA and ORF expression clones, recombinant proteins, RNA interference tools (shRNA, miRNA), custom cloning services, and gene editing technologies such as CRISPR-Cas9 and TALEN. Fulengen offers genome editing solutions encompassing Cas9 proteins, sgRNA libraries, stable cell lines, validation systems, and gene knock-in kits, supporting gene editing research workflows. The company also provides miRNA research tools, qPCR reagents and arrays for gene and miRNA expression profiling, viral vector systems for gene delivery, and nucleic acid virus detection kits for pandemic-related research. Fulengen collaborates with international research institutions and biotech companies, contributing to human genome projects and developing protein expression databases. | Voorzitter | - |
Eerdere bekende functies van Cui Ling Wu
| Bedrijven | Functie | Einde |
|---|---|---|
| DAAN GENE CO., LTD. | Directeur/Bestuurslid | 27-05-2022 |
| GUANGZHOU WONDFO BIOTECH CO.,LTD | Voorzitter | - |
Opleiding van Cui Ling Wu
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
73
Eerstegraads connecties
6
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Daan Gene Co., Ltd.
 Daan Gene Co., Ltd. BiotechnologyHealth Technology Manufactures and distributes molecular biology based reagents & medical equipment | Health Technology |
Guangzhou Bio-tech Pharmaceuticals Center | |
Guangzhou Wondfo Biotech Co., Ltd.
 Guangzhou Wondfo Biotech Co., Ltd. BiotechnologyHealth Technology Engages in the manufacture, sale of biochemical reagents, medical products and diagnostic test kits | Health Technology |
Sun Yat-Sen University
Sun Yat-Sen University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Guangdong Pharmaceutical University
 Guangdong Pharmaceutical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Guangzhou Fulengen Co., Ltd.
Guangzhou Fulengen Co., Ltd. Guangzhou Fulengen Co., Ltd. is a biotechnology and life science research company specializing in genome editing tools, gene function research, and molecular biology products. The company is based in Guangzhou, China. The Chinese company develops and promotes a broad portfolio of products, including full-length cDNA and ORF expression clones, recombinant proteins, RNA interference tools (shRNA, miRNA), custom cloning services, and gene editing technologies such as CRISPR-Cas9 and TALEN. Fulengen offers genome editing solutions encompassing Cas9 proteins, sgRNA libraries, stable cell lines, validation systems, and gene knock-in kits, supporting gene editing research workflows. The company also provides miRNA research tools, qPCR reagents and arrays for gene and miRNA expression profiling, viral vector systems for gene delivery, and nucleic acid virus detection kits for pandemic-related research. Fulengen collaborates with international research institutions and biotech companies, contributing to human genome projects and developing protein expression databases. |
Kies MarketScreener 
